Marex Group’s Globus Medical GMED Stock Holding History

Marex Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,290	Closed	-$314K	–	769
2025 Q1	$314K	Buy	+4,290	New	+$354K	0.01%	445

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Marex Group's GMED Position: Q2 2025 in Review

Marex Group sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 4,290 shares — an estimated $314K sold.

Marex Group first reported a position in GMED in Q1 2025 and held it in 1 quarter. The position peaked at $314K in Q1 2025. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

Marex Group reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
Marex Group sold 4,290 Globus Medical shares in Q2 2025, an estimated $314K.
Marex Group first reported a position in Globus Medical in Q1 2025 and held it in 1 quarter.
Marex Group's Globus Medical position peaked at $314K in Q1 2025.
480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.